Therefore, herein, we investigated the impact of sleeping habits on the weight loss effect of semaglutide, a daily oral GLP-1 RA, among Japanese individuals with obesity. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.